Le Lézard
Classified in: Health
Subjects: PDT, VET, CFG

Veterans Affairs Canada Launches New Mental Health Benefits


Veterans applying for a disability benefit for certain mental health conditions will now receive immediate mental health coverage.

CHARLOTTETOWN, PEI, April 1, 2022 /CNW/ - The Honourable Lawrence MacAulay, Minister of Veterans Affairs and Associate Minister of National Defence, and the Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health announced today that eligible Canadian Armed Forces (CAF) Veterans, including certain serving classes of Reservists, applying for a disability benefit for certain mental health conditions will now receive immediate mental health coverage. These Mental Health Benefits were announced in Budget 2021.

Coverage applies to treatments for anxiety, depressive, and trauma-and-stressor-related disorders. It lasts for two years starting when the disability benefits application is submitted, regardless of whether it is ultimately approved. If the disability benefit application is approved, treatment will be covered for as long as necessary through Veterans Affairs Canada's Treatment Benefits program.

This initiative is part of the Department's ongoing work to address the unique health needs of Veterans. Reservists on Class A or Class B (less than 180 days), as well as Veterans and Reservists living outside of Canada, also qualify for Mental Health Benefits. 

Quotes

"Getting access to mental health treatment is vital to Veterans' well-being. The Mental Health Benefit will make sure that Veterans get coverage for the mental health support and services they need, as fast as possible. It's the right thing to do for the thousands who've stepped forward to serve our country."

The Honourable Lawrence MacAulay, Minister of Veterans Affairs and Associate Minister of National Defence

"Veterans have courageously served and protected our communities and country and, like all Canadians, deserve fast access to mental health treatments and services which meet their unique needs. Our government recognizes that there is no health without mental health, and is committed to improving the well-being and mental health of all those who have served."

The Honourable Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health

"The decision by Veterans Affairs Canada to provide immediate mental health benefits to eligible Veterans is the right one. We are elated to see this change because Veterans will not have to wait for claims processing and will receive timely and critical help when they need it most."

Bruce Julian, Dominion President, The Royal Canadian Legion

Quick facts
Associated links

SOURCE Veterans Affairs Canada


These press releases may also interest you

at 08:45
The "China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. This market research report provides key insights into the industry's rapid growth...

at 08:45
Lake Superior State University (LSSU), a rural, public college located in Michigan's upper peninsula, announced the launch of a new university-wide initiative designed to provide increased teletherapy and crisis support....

at 08:40
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, will showcase significant contributions in preclinical and translational oncology research at the American Association for Cancer Research (AACR) 2024...

at 08:38
HFA Architecture + Engineering has expanded its healthcare design team with the addition of Principal and Healthcare Practice Leader Paul Sabal (AIA, ACHA, NCARB, LEED AP).  Sabal is a registered architect and interior designer with more than four...

at 08:35
NanoVibronix, Inc. ("NanoVibronix" or the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...



News published on and distributed by: